152 related articles for article (PubMed ID: 28609305)
1. Phenelzine Withdrawal-Associated Psychosis and Mania.
Shao W; Brown T; Ayub S
J Clin Psychopharmacol; 2017 Aug; 37(4):480-482. PubMed ID: 28609305
[No Abstract] [Full Text] [Related]
2. Mania or hypomania after withdrawal from antidepressants.
Hartmann PM
J Fam Pract; 1990 Apr; 30(4):471-2. PubMed ID: 2324698
[No Abstract] [Full Text] [Related]
3. Phenelzine-induced fulminant hepatic failure.
Gómez-Gil E; Salmerón JM; Mas A
Ann Intern Med; 1996 Apr; 124(7):692-3. PubMed ID: 8607601
[No Abstract] [Full Text] [Related]
4. Mania during antidepressant withdrawal in late-onset depression.
Singh A; Alexopoulos GS
Int J Geriatr Psychiatry; 2013 Jun; 28(6):654-5. PubMed ID: 23649859
[No Abstract] [Full Text] [Related]
5. Seizures in a diabetic patient on monoamine oxidase inhibitors.
Albareda M; Udina C; Escartín A; Corcoy R
Am J Emerg Med; 1999 Jan; 17(1):107-8. PubMed ID: 9928719
[No Abstract] [Full Text] [Related]
6. Nightmares during phenelzine withdrawal.
Joyce PR; Walshe J
J Clin Psychopharmacol; 1983 Apr; 3(2):121. PubMed ID: 6841661
[No Abstract] [Full Text] [Related]
7. The hepatic injury of monoamine oxidase inhibitors.
Zimmerman HJ; Ishak KG
J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504
[No Abstract] [Full Text] [Related]
8. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
[No Abstract] [Full Text] [Related]
9. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
Goff DC
Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
[TBL] [Abstract][Full Text] [Related]
10. Psychosis following phenelzine discontinuation.
J Clin Psychopharmacol; 1985 Dec; 5(6):360-1. PubMed ID: 4067006
[No Abstract] [Full Text] [Related]
11. Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
McGrath PJ; Stewart JW; Tricamo E; Nunes EN; Quitkin FM
J Clin Psychopharmacol; 1993 Jun; 13(3):224-5. PubMed ID: 8354742
[No Abstract] [Full Text] [Related]
12. Mania associated with high percentage of inhibition of monoamine oxidase.
Bowden CL; Seleshi E; Javors MA
Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
[No Abstract] [Full Text] [Related]
13. Paradoxical mood changes during pharmacotherapy of bipolar patients.
Kusalic M; Ghadirian AM
Biol Psychiatry; 1990 May; 27(10):1183-4. PubMed ID: 2340327
[No Abstract] [Full Text] [Related]
14. Possible antidepressant-associated activation of mania and psychosis in the mentally retarded: four case reports.
Sahay N; Muscat E; Bowers MB
J Clin Psychiatry; 2003 Apr; 64(4):481-2. PubMed ID: 12716255
[No Abstract] [Full Text] [Related]
15. Mania and drug withdrawal.
Ostow M
J Clin Psychopharmacol; 1984 Apr; 4(2):118. PubMed ID: 6707239
[No Abstract] [Full Text] [Related]
16. Phenelzine-induced sexual dysfunction treated with sildenafil.
Gupta S; Masand P; Ashton AK; Berry SL
J Sex Marital Ther; 1999; 25(2):131-5. PubMed ID: 10327382
[TBL] [Abstract][Full Text] [Related]
17. [Irreversible, non-selective monoamine oxidase inhibitors].
Castberg I; Spigset O
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of MAO inhibition.
Baxter LR
J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
[No Abstract] [Full Text] [Related]
19. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
Landolt HP; de Boer LP
Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant withdrawal-induced activation (hypomania and mania): is withdrawal-induced cholinergic overdrive causally significant?
Dilsaver SC; Greden JF
J Clin Psychopharmacol; 1984 Jun; 4(3):174-5. PubMed ID: 6736282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
